TAG:
laboratory business
Lab/Path M&A Day Explores High Prices Paid to Lab Owners
By Robert Michel | From the Volume XV No. 3 – March 3, 2008 Issue
IF YOU HAVEN’T NOTICED, there’s a gold rush in diagnostics! Prices paid for clinical laboratories, anatomic pathology group practices, and in vitro diagnostic (IVD) companies have soared recently. This is good news for pathologists and laboratory owners interested in putting their laboratory on …
March 03, 2008 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XV No. 3 – March 3, 2008 Issue
Another laboratory company is suing the federal government. On January 24, UroPath, LLC and three urology groups filed a lawsuit in the U.S. District Court for the District of Columbia. UroPath, the largest operator of anatomic pathology (AP) condo/pod laboratory complexes, is suing …
Siemens Acquires Dade, Builds IVD Powerhouse
By Robert Michel | From the Volume XIV No. 11 – August 6, 2007 Issue
CEO SUMMARY: In just 15 months, Siemens AG has pulled out its checkbook three times to spend more than $14 billion to acquire major in vitro diagnostics (IVD) companies. When it closes the purchase of Dade Behring, Siemens will be in the first rank of global IVD manufacturers. It has also…
DSI Sale Shows Value of Lab Outreach Program
By Robert Michel | From the Volume XIV No. 9 – June 25, 2007 Issue
CEO SUMMARY: For other hospital laboratory outreach programs, the pending sale of DSI Laboratories, Inc., of Fort Meyers, Florida, to Laboratory Corporation of America provides useful insights about the market value of these programs. Applying general formulas for determining a sales pric…
Sonic Pays $180 Million In Acquisition of AEL
By Robert Michel | From the Volume XIII No. 17 – December 18, 2006 Issue
CEO SUMMARY: In a transaction that was quietly negotiated, Sonic Healthcare Ltd. will purchase American Esoteric Laboratories, Inc. (AEL). News of the sale was released Friday and the sale may close in early January. Once it owns AEL, Sonic will have a major presence in Memphis, Tennessee…
New & Stefanelli Launch Anatomic Path Venture
By Robert Michel | From the Volume XIII No. 16 – November 27, 2006 Issue
CEO SUMMARY: With little fanfare, Aurora Diagnostics, Inc. opened for business last summer. It states that it has already signed acquisition agreements with five different pathology groups. Former AmeriPath executives James C. New and Martin J. Stefanelli are leading Aurora Diagnostics. H…
Buyer of MDS’ Canadian Labs Agrees to Pay C$ 900 Million
By Robert Michel | From the Volume XIII No. 13 – September 25, 2006 Issue
CANADA’S LARGEST CHAIN OF CLINICAL LABORATORIES will change hands in a deal revealed on September 7, 2006 by Toronto’s The Globe and Mail. MDS Inc. will apparently sell its diagnostics division to Borealis Infrastructure Management Inc., a private equit…
Three Ex-UroCor Execs Acquitted in Jury Trial
By Robert Michel | From the Volume XIII No. 10 – July 24, 2006 Issue
CEO SUMMARY: On June 30, 2006,three former executives of UroCor,Inc.,accused by the U.S. Attorney of anti-kickback and securities violations, stood and heard the jury verdict in their case. “Not guilty on all counts,” stated the jury foreman. Thus ended the effort to convict former ex…
New Lab Firm Life Cycle Demonstrated by Focus
CEO SUMMARY: When an investment group bought Focus Diagnostics, Inc. in 2000, its business objective was to increase the value of the business and sell it between year five and ten of its ownership. Thus, the announcement last Friday that Focus Diagnostics would be acquired by Quest Diagn…
MDS Sells Calgary Lab, May Spin Off Other Labs
CEO SUMMARY: Nine months after it declared that it would exit the laboratory testing business in Canada by selling its laboratories, MDS, Inc. has finally closed its first sale. Calgary Health Region, already a 50% owner of Calgary Laboratory Services, has purcha…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized